CNS Drug Development―One Partner From Discovery to Market

Overview


CNS-Drug-Development-One-Partner-From-Discovery-to-Market.png

As a leading partner in central nervous system (CNS) drug development, Altasciences’ in-house preclinical, clinical, bioanalytical, and manufacturing teams have decades of experience formulating, testing, and manufacturing pharmaceutical products that treat various CNS disorders.

Read the latest issue of The Altascientist to learn about the complexities of CNS drug development programs and how our comprehensive offering can reduce your timelines by up to 40%.

Three case studies included!

Download your copy today!

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of Outsourcing-Pharma.com

Download Now


Related Resources

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences

White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs), including: a review of the relevant guidance HPAPI classification systems safety processes...

Tackling Early Phase Development with First-In-Human Study Solutions

Tackling Early Phase Development with First-In-Human Study Solutions

Content provided by Altasciences

White Paper

Bringing new drugs to market, from lead candidate selection through preclinical testing, to clinical proof of concept, is a complex, time-consuming, and costly process. At Altasciences, we simplify the journey for you, and deliver a stress-free...

Supplier Info Centre

Altasciences.jpg

For more product information visit Altasciences.